Your browser doesn't support javascript.
loading
Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia.
Lamothe, Betty; Cervantes-Gomez, Fabiola; Sivina, Mariela; Wierda, William G; Keating, Michael J; Gandhi, Varsha.
Afiliación
  • Lamothe B; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cervantes-Gomez F; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sivina M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Gandhi V; Departments of Experimental Therapeutics and Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood ; 125(2): 407-10, 2015 Jan 08.
Article en En | MEDLINE | ID: mdl-25573971
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article